Observational, Cross-Sectional Post-Authorisation Safety Study to Assess Healthcare Provider Awareness of Risks Related to Sofosbuvir and Ledipasvir/Sofosbuvir (EU HVN SOF Survey Study)

08/09/2016
31/03/2024
EU PAS number:
EUPAS15103
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

1.2-Prot GS-EU-337-2030 FINAL SIGNED

English (908.64 KB - PDF) View document
Study results
Study results

GS-EU-337-2030+ABSTRACT+Clinical+Study+Report

English (102.32 KB - PDF) View document
Study report
Other information